This Registry study will prospectively evaluate the differences in treatment outcomes in terms of pain intensity, pain interference, concomitant medication use, health-related quality of life, opioid adverse effects, and healthcare utilization between targeted drug delivery and conservative medication management only groups.
Cancer Pain, Chronic Pain, Cancer Associated Pain, Neuropathic Pain
This Registry study will prospectively evaluate the differences in treatment outcomes in terms of pain intensity, pain interference, concomitant medication use, health-related quality of life, opioid adverse effects, and healthcare utilization between targeted drug delivery and conservative medication management only groups.
Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
-
Advocate Aurora Health, Oshkosh, Wisconsin, United States, 54904
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
21 Years to
ALL
No
Wake Forest University Health Sciences,
Mansoor M Aman, MD, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences
2025-12-06